To evaluate the correlation between serum zinc level with CD4 count before and after zinc supplemention.
Not Applicable
- Conditions
- Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
- Registration Number
- CTRI/2021/11/038057
- Lead Sponsor
- Amit Das
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
HIV positive patients who are willing to participate
Exclusion Criteria
1.terminally ill patients
2.Any co-morbid conditions(sepsis, renal impairment, liver impairment, malignancy or under chemotherapy.
3.pregnancy
4.HIV positive patients already on zinc supplementation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method serum zinc level in hiv patients at baseline.Timepoint: 3 months
- Secondary Outcome Measures
Name Time Method serum zinc level after 3months and its correlation with CD4 count.Timepoint: 3 months